Showing results (1-10 of 59) with videos related to
Sort By:
Pageof 6
Expert Review of Anticancer Therapy|July 13, 2002
Temozolomide: a novel oral alkylating agentS J Danson, M R MiddletonJournal of Adolescence|March 1, 1985
The Family Functioning in Adolescence Questionnaire: a measure of psychosocial family health during adolescenceR Roelofse, M R MiddletonBritish Journal of Cancer|July 8, 2015
The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumoursS J Thomas, J A Snowden, M P Zeidler, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2014
A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stageJ M Findlay, M R Middleton, I TomlinsonJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2000
Post hoc economic analysis of temozolomide versus dacarbazine in the treatment of advanced metastatic melanomaB E Hillner, S Agarwala, M R MiddletonCritical Reviews in Oncology/Hematology|February 19, 2005
Temozolomide in the treatment of solid tumours: current results and rationale for dosing/schedulingM J Payne, S E Pratap, M R MiddletonCancer Chemotherapy and Pharmacology|January 27, 2000
Four-hourly scheduling of temozolomide improves tumour growth delay but not therapeutic index in A375M melanoma xenograftsM R Middleton, J Kelly, S Goodger, et al.International Journal of Cancer|October 31, 2000
O6-methylguanine formation, repair protein depletion and clinical outcome with a 4 hr schedule of temozolomide in the treatment of advanced melanoma: results of a phase II studyM R Middleton, S M Lee, A Arance, et al.European Radiology|September 8, 2010
Additional benefit of ¹⁸F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancerR S Gillies, M R Middleton, N D Maynard, et al.Journal of Skin Cancer|October 29, 2013
Melanoma in buckinghamshire: data from the inception of the skin cancer multidisciplinary teamJ J Cubitt, A A Khan, E Royston, et al.Pageof 6